Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DU6H3C
|
|||
| Drug Name |
Allo-APZ2-EB
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Epidermolysis bullosa [ICD-11: EC3Z] | Phase 1/2 | [1] | |
| Company |
RHEACELL
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03529877) An Interventional, Multicenter, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-EB on Epidermolysis Bullosa (EB). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.